In focus · trending topic

Frontier Pharm

1 stories · following the connections

Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes: ResearchMoz

By Nasdaq OMXSep 16, 2016, 11:05 AM UTC